NIPH Clinical Trials Search

UMIN ID: UMIN000001392

Registered date:26/09/2008

A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005).

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedNon-small cell lung cancer
Date of first enrollment2006/01/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Vinorelbine+ Thoracic radiotherapy


Primary OutcomeTo determine recommended dose
Secondary OutcomeSafety, Response rate, 2-year survival rate, progression free suevival.

Key inclusion & exclusion criteria

Age minimum71years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaInterstitial pneumonia. No eligibility for definitive radiotherapy.

Related Information


public contact
Name Shinichiro Nakamura
Address Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku,Osaka556-0016 JAPAN Japan
Telephone 06-6633-7400
Affiliation West Japan Oncology Group WJOG datacenter
scientific contact
Name Hideyuki Harada
Address Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan Japan
Telephone 055-989-5222
Affiliation Shizuoka Cancer Center Radiation Oncology